Records whose title is actually about this topic. Use a country filter if the list is still too broad.
Records
Bill· SS. 895 (118th)referred
United States · United States Congress · 21 March 2023
Ellie Helton, Lisa Colagrossi, Kristen Shafer Englert, Teresa Anne Lawrence, and Jennifer Sedney Focused Research Act or Ellie's Law This bill authorizes appropriations for the National Institute of Neurological Disorders and Stroke to conduct or support research on unruptured brain aneurysms in a patient population diversified by age, sex, and race.
Bill· SS. 880 (118th)referred
United States · United States Congress · 21 March 2023
Coordinating Dual Eligible Recommendations Act This bill requires the Medicare Payment Advisory Commission and the Medicaid and Children's Health Insurance Program (CHIP) Payment and Access Commission to jointly submit a biennial report on Medicare and Medicaid with respect to dually eligible beneficiaries, including information relating to finances, utilization, and coordination of services.
Resolution· SRESS.Res. 116 (118th)passed
United States · United States Congress · 21 March 2023
This resolution expresses support for Deep Vein Thrombosis and Pulmonary Embolism Awareness Month. Deep vein thrombosis is a condition caused by a blood clot in the deep veins of the body; pulmonary embolisms (i.e., where a blood clot breaks off and lodges in the lung) are a potentially life-threatening complication of this condition.
Bill· HRH.R. 1666 (118th)referred
United States · United States Congress · 17 March 2023
Protecting Access to Ground Ambulance Medical Services Act of 2023 This bill extends the specialized rate increase for Medicare payment of ground ambulance services in rural areas for an additional three years (until January 1, 2028).
Bill· HRH.R. 1638 (118th)referred
United States · United States Congress · 17 March 2023
Improving Access to Mental Health Act of 2023 This bill increases the Medicare reimbursement rate for clinical social worker services. The bill excludes clinical social worker services from the prospective payment system in which predetermined amounts form the basis for payment under Medicare. Additionally, the bill alters the definition of clinical social worker services as it relates to Medicare. Under current law, such services (1) include services performed for the diagnosis and treatment of mental illnesses, and (2) exclude services furnished to an inpatient of a skilled nursing facility as a condition of the facility's participation in the Medicare program. The bill repeals these provisions and instead specifies that such services include certain types of health behavior assessment and intervention.
Bill· HRH.R. 1617 (118th)referred
United States · United States Congress · 17 March 2023
Prevent Interruptions in Physical Therapy Act of 2023 This bill allows a physical therapist to receive payment under Medicare for services provided to the physical therapist's patients by another physical therapist through a qualifying temporary arrangement, regardless of the geographic area or population served. Currently, physical therapists may only receive payment with respect to such arrangements for services provided in medically underserved, rural, or health professional shortage areas.
Bill· HRH.R. 1634 (118th)referred
United States · United States Congress · 17 March 2023
Helping Ensure Life- and Limb-Saving Access to Podiatric Physicians Act or the HELLPP Act This bill adds podiatrists as covered physicians under the Medicaid program. Additionally, the bill revises certain documentation requirements related to Medicare coverage of therapeutic shoes for individuals with diabetes. Finally, the bill subjects payments made to a Medicaid provider or supplier to a continuing levy for federal taxes owed by the provider or supplier.
Bill· HRH.R. 1616 (118th)referred
United States · United States Congress · 17 March 2023
Comprehensive Access to Resources and Education for Long COVID Act or the CARE for Long COVID Act This bill requires research, education, and other activities to support individuals who have Long COVID or related conditions that may result directly, or indirectly, from COVID-19 infection. The Department of Health and Human Services (HHS) must support a voluntary patient registry to collect information about individuals with Long COVID and related conditions, such as their symptoms, treatments, and demographic characteristics. HHS must coordinate with the Patient-Centered Outcomes Research Institute on the registry. HHS must also conduct or support research along with other agencies on how the U.S. health care system responds to Long COVID and related conditions. This includes research on the effectiveness of treatments and strategies to mitigate disparities in health outcomes. In addition, HHS must (1) educate the public and health care providers about treatments for, conditions associated with, and other aspects of Long COVID and related conditions; and (2) disseminate information and resources on how Long COVID affects rights associated with employment, disability status, and education. Last, the Administration for Community Living must award grants to or enter contracts with states, health care providers, legal services providers, and other eligible entities for expanding access to legal assistance for individuals with Long COVID and related conditions, including assistance with obtaining Social Security and other benefits and accessing medical care and services.
Bill· HRH.R. 1620 (118th)referred
United States · United States Congress · 17 March 2023
Maximizing Opioid Recovery Emergency Savings Act or the MORE Savings Act This bill modifies coverage of opioid treatments and recovery support services under Medicare, Medicaid, and private health insurance. Specifically, the bill requires the Center for Medicare and Medicaid Innovation to test a model in which specified opioid treatments and recovery support services are provided under Medicare without cost-sharing (e.g., coinsurance, copayments, and deductibles). The bill also allows state Medicaid programs to cover recovery support services as part of medication-assisted treatment (MAT) and increases the applicable Federal Medical Assistance Percentage for MAT. Additionally, beginning in 2025, private health insurers must cover specified opioid treatments and MAT-associated recovery support services without cost-sharing.
Bill· HRH.R. 1637 (118th)referred
United States · United States Congress · 17 March 2023
Comprehensive Care for Alzheimer's Act This bill allows the Center for Medicare and Medicaid Innovation (CMMI) to test a Dementia Care Management Model that provides comprehensive care to Medicare beneficiaries with Alzheimer's disease or a related dementia. Under the model, participating health care providers receive payment under Medicare for comprehensive care management services that are provided to individuals with diagnosed dementia, excluding Medicare Advantage enrollees, hospice care recipients, and nursing home residents. Required services include medication management, care coordination, and health, financial, and environmental monitoring, as well as trainings and other support services for unpaid caregivers. Providers must furnish services through interdisciplinary teams and must ensure access to a team member or primary care provider 24-7. The CMMI must set payments and determine quality measures for the model in accordance with specified requirements. The bill also allows the CMMI to design a similar model under Medicaid.
Bill· HRH.R. 1628 (118th)referred
United States · United States Congress · 17 March 2023
CBD Product Safety and Standardization Act of 2023 This bill requires the Food and Drug Administration (FDA) to regulate food containing cannabidiol (CBD) derived from hemp as a food additive. (The FDA has determined that food containing added CBD cannot be sold in interstate commerce.) Under this bill, in order to be sold, a food containing CBD derived from hemp must conform with current FDA requirements pertaining to food additives or be generally recognized as safe (GRAS). (Under current law, a food additive with the GRAS designation is not subject to FDA premarket review and approval requirements.) In addition, such a food must comply with all other relevant FDA and labeling requirements. Such a food shall be exempt from an existing provision that prohibits the sale of a food containing an additive that is (1) an FDA-approved drug or biological product, or (2) subject to certain clinical investigations. The FDA must issue regulations pertaining to such foods that specify (1) the maximum amount of CBD derived from hemp per serving, (2) labeling and packaging requirements, and (3) any conditions for intended use.
Bill· HRH.R. 1629 (118th)referred
United States · United States Congress · 17 March 2023
Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023 This bill allows the use of hemp, cannabidiol (i.e., CBD) derived from hemp, or any other ingredient derived from hemp in a dietary supplement, provided that the supplement meets other applicable requirements. (Currently, the Food and Drug Administration's position is that CBD products may not be sold as dietary supplements.)
Bill· HRH.R. 1613 (118th)referred
United States · United States Congress · 17 March 2023
Drug Price Transparency in Medicaid Act of 2023 This bill requires pass-through pricing models, and prohibits spread-pricing, for payment arrangements with pharmacy benefit managers under Medicaid. The bill also extends funding for retail pharmacy surveys and requires additional information with respect to price concessions and survey participation to be made publicly available.
Report· HearingS.Hrg.118-55published
United States · United States Senate · 16 March 2023
Bill· SS. 842 (118th)referred
United States · United States Congress · 16 March 2023
Medicare and Medicaid Dental, Vision, and Hearing Benefit Act of 2023 This bill provides for Medicare coverage of dental, vision, and hearing care. Coverage includes (1) routine dental cleanings and exams, basic and major dental services, emergency dental care, and dentures; (2) routine eye exams, eyeglasses, and contact lenses; and (3) routine hearing exams, hearing aids, and exams for hearing aids. With respect to such care, the bill establishes special payment rules, limitations, and coinsurance requirements. The bill also increases the Medicaid Federal Medical Assistance Percentage (i.e., federal matching rate) for dental, vision, and hearing services.
Bill· SS. 844 (118th)referred
United States · United States Congress · 16 March 2023
Assistance for Local Heroes During Train Crises Act This bill establishes a Hazardous Train Event Emergency Reimbursement Fund for state and local emergency response groups. Specifically, upon a declaration by the Federal Railroad Administration (FRA) that a hazardous train event has occurred, the FRA must immediately award at least $250,000 from the emergency fund to one or more eligible groups (e.g., law enforcement agencies and fire departments). Additional amounts may be awarded, but may not exceed $3 million per hazardous train event. The FRA may declare a hazardous train event has occurred following a derailment or crash involving a train carrying hazardous materials, hazardous waste, or other materials that pose a threat to public health, safety, and the environment. Costs associated with a response to a hazardous train event that are eligible for reimbursement include (1) replacing damaged or contaminated equipment; (2) overtime pay for firefighters, law enforcement officers, or other emergency responders; and (3) retroactively covering these types of incurred costs after the event date. The FRA must also (1) establish annual fees for shippers and carriers of hazardous materials by rail that have total annual collections of at least $10 million, and (2) deposit the fees into the reimbursement fund. Further, the Department of Transportation must issue regulations requiring railroads that transport hazardous materials by train to provide county and local emergency response groups with (1) advanced warning of the train's load and timing, and (2) real-time location information on the train when it enters and exits the community's service area.
Bill· SS. 862 (118th)referred
United States · United States Congress · 16 March 2023
Restoring America's Health Care Workforce and Readiness Act This bill extends and increases enhanced funding for the National Health Services Corps (NHSC) through FY2026 and establishes an emergency services demonstration program within the Department of Health and Human Services (HHS) to provide supplemental student loan repayment to current and former NHSC participants. The NHSC provides scholarships and student loan repayment awards to health care providers who agree to work in areas with health care provider shortages. To receive supplemental payments, individuals must agree to participate in the National Disaster Medical System. This system is a partnership between HHS, the Department of Defense, and other federal departments that responds to public health and other emergencies, including by deploying medical response teams.
Bill· SS. 845 (118th)referred
United States · United States Congress · 16 March 2023
Short on Competition Act This bill requires the Food and Drug Administration (FDA) to provide temporary authorization to import certain prescription drugs facing shortages or in a marginally competitive drug market. Specifically, the FDA shall authorize importation of an eligible drug that is lifesaving, life-sustaining, or intended to treat or prevent a debilitating condition. To be eligible, a drug must (1) be facing a shortage, (2) require a prescription, (3) have received market authorization in certain foreign countries, and (4) have the same active ingredient as the drug for which there is a shortage in the United States. The drug's manufacturer must also seek FDA approval for the drug as a generic drug. The import authorization shall be for three years or until the shortage no longer applies, whichever occurs first. Importation shall begin within 60 days of the FDA receiving an application that meets all of the applicable requirements. The FDA may deny importation of a drug for reasons related to safety or effectiveness. Drugs in marginally competitive markets must be treated as being in a shortage for the purposes of this bill and for the purposes of expedited inspections and review. A drug is in a marginally competitive market if (1) there are fewer than five holders of approved applications for commercially available brand-name or generic versions of the drug, (2) the drug has been approved for at least 10 years, and (3) the patents on the drug's active ingredients have expired.
Bill· SS. 838 (118th)referred
United States · United States Congress · 16 March 2023
Improving Access to Mental Health Act of 2023 This bill increases the Medicare reimbursement rate for clinical social worker services. The bill excludes clinical social worker services from the prospective payment system in which predetermined amounts form the basis for payment under Medicare. Additionally, the bill alters the definition of clinical social worker services as it relates to Medicare. Under current law, such services (1) include services performed for the diagnosis and treatment of mental illnesses, and (2) exclude services furnished to an inpatient of a skilled nursing facility as a condition of the facility's participation in the Medicare program. The bill repeals these provisions and instead specifies that such services include certain types of health behavior assessment and intervention.
Bill· SS. 856 (118th)referred
United States · United States Congress · 16 March 2023
Funding Affordable Internet with Reliable Contributions Act or the FAIR Contributions Act This bill requires the Federal Communications Commission (FCC) to study and report on the feasibility of funding the Universal Service Fund through contributions from edge providers (i.e., providers of online content or services, such as search engines). The fund provides support for broadband and other telecommunications services to high-cost areas, schools and libraries, rural health care facilities, and the Lifeline program (an FCC program that provides a discount on phone and internet services for low-income consumers). The report must consider (1) the type and size of firms and services on which contributions could be assessed, (2) equity issues related to current versus alternative systems for contributing to the fund, (3) the effect of any change to the contribution system on the telecommunications bills of consumers, and (4) the sustainability of the fund and how to ensure that fund disbursements are consistent and predictable over time.
Bill· SS. 822 (118th)open
United States · United States Congress · 15 March 2023
Modification to Department of Defense Travel Authorities for Abortion-Related Expenses Act of 2023 This bill prohibits the Department of Defense (DOD) from providing certain funding related to abortion services. First, the bill terminates the DOD memorandum titled Ensuring Access to Reproductive Health Care (October 20, 2022). Such memo sets forth DOD policies and procedures in response to the Supreme Court's ruling in Dobbs v. Jackson Women's Health Organization . Under the bill, DOD may not obligate or expend funds to carry out the objectives of the memo or any successor memo. Next, the bill prohibits DOD from providing any actual or necessary expenses of travel or transportation related to official travel for a member of the Armed Forces or a dependent of such a member who is seeking an abortion or any abortion-related service (except in the case of rape or incest, or when the mother's life is in danger). The bill provides that limited access of a member of the Armed Forces or a dependent to an abortion or abortion-related services due to the member's duty location does not constitute an unusual, extraordinary, hardship, or emergency circumstance for which travel and transportation allowances may be provided (except in the case of rape or incest, or when the mother's life is in danger). The bill also prohibits a member of the Armed Forces from taking convalescent leave or using an administrative absence for travel related to receiving an abortion or abortion-related service (except in the case of rape or incest, or when the mother's life is in danger).
Bill· SS. 807 (118th)referred
United States · United States Congress · 15 March 2023
Return Employees to Understaffed Work Sites to Reopen Now Act of 2023 or the RETURN Act of 2023 This bill requires each federal agency to submit to Congress and publish on the agency's website a plan for the agency to resume in-person operations. The plan shall, among other things, include the agency's policy with respect to permitting permanent remote work for employees who can successfully achieve their duties away from their official work sites, metrics to measure the productivity of employees performing remote work to identify employees that fail to fulfill their duties, a plan to provide essential government services in person for individuals in the United States, and measures to prepare for future public health emergencies that can be quickly implemented if remote work becomes necessary. Each agency must submit a report to the General Services Administration recommending termination of the agency's leases of physical work spaces that are underused.
Bill· SS. 803 (118th)referred
United States · United States Congress · 15 March 2023
Save Rural Hospitals Act of 2023 This bill establishes an area wage adjustment floor for Medicare hospital payments in states that are not frontier states and excludes such adjustments from certain budget neutrality rules.
Bill· SS. 801 (118th)referred
United States · United States Congress · 15 March 2023
Comprehensive Access to Resources and Education for Long COVID Act or the CARE for Long COVID Act This bill requires research, education, and other activities to support individuals who have Long COVID or related conditions that may result directly, or indirectly, from COVID-19 infection. The Department of Health and Human Services (HHS) must support a voluntary patient registry to collect information about individuals with Long COVID and related conditions, such as their symptoms, treatments, and demographic characteristics. HHS must coordinate with the Patient-Centered Outcomes Research Institute on the registry. HHS must also conduct or support research along with other agencies on how the U.S. health care system responds to Long COVID and related conditions. This includes research on the effectiveness of treatments and strategies to mitigate disparities in health outcomes. In addition, HHS must (1) educate the public and health care providers about treatments for, conditions associated with, and other aspects of Long COVID and related conditions; and (2) disseminate information and resources on how Long COVID affects rights associated with employment, disability status, and education. Last, the Administration for Community Living must award grants to or enter contracts with states, health care providers, legal services providers, and other eligible entities for expanding access to legal assistance for individuals with Long COVID and related conditions, including assistance with obtaining Social Security and other benefits and accessing medical care and services.
Bill· SS. 818 (118th)referred
United States · United States Congress · 15 March 2023
Maximizing Opioid Recovery Emergency Savings Act or the MORE Savings Act This bill modifies coverage of opioid treatments and recovery support services under Medicare, Medicaid, and private health insurance. Specifically, the bill requires the Center for Medicare and Medicaid Innovation to test a model in which specified opioid treatments and recovery support services are provided under Medicare without cost-sharing (e.g., coinsurance, copayments, and deductibles). The bill also allows state Medicaid programs to cover recovery support services as part of medication-assisted treatment (MAT) and increases the applicable Federal Medical Assistance Percentage for MAT. Additionally, beginning in 2025, private health insurers must cover specified opioid treatments and MAT-associated recovery support services without cost-sharing.
Bill· HRH.R. 1587 (118th)referred
United States · United States Congress · 14 March 2023
Making Insulin Affordable for All Children Act This bill limits cost-sharing for insulin under private health insurance and Medicaid for individuals who are 26 years of age or younger. Specifically, the bill caps cost-sharing under private health insurance and Medicaid for these individuals for a month's supply of selected insulin products at $35 or 25% of a plan's negotiated price (after any price concessions), whichever is less, beginning in 2024.
Bill· HRH.R. 1610 (118th)referred
United States · United States Congress · 14 March 2023
Chiropractic Medicare Coverage Modernization Act of 2023 This bill expands Medicare coverage of chiropractic services to include all services provided by chiropractors, rather than only subluxation corrections through manual manipulation of the spine.
Bill· HRH.R. 1575 (118th)referred
United States · United States Congress · 14 March 2023
Pregnancy Center Security Act This bill requires the Department of Health and Human Services to award grants on a competitive basis for upgrading the facilities of pregnancy-help organizations. The bill defines these as organizations that provide services to individuals with unintended pregnancies with the intent of encouraging the individuals to give birth; the definition in the bill excludes, however, organizations that perform or refer for abortions (or affiliates of those organizations). Facility upgrades include installing security systems and making the facilities accessible to people with disabilities. The bill prohibits the use of grant funds for abortion-related services.
Resolution· HRESH.Res. 232 (118th)referred
United States · United States Congress · 14 March 2023
This resolution supports the designation of Sleep Awareness Week.
Bill· SS. 782 (118th)referred
United States · United States Congress · 14 March 2023
Furthering Resource Exploration and Empowering American Energy Act or the FREE American Energy Act This bill expedites the review of energy projects, limits executive power over certain energy projects, delegates certain energy permitting authority to states, provides statutory authority for specified environmental rules, and terminates tax credits for certain vehicles. Specifically, the bill establishes deadlines by which applicable federal agencies must approve or deny permits or other authorizations for certain natural gas, oil, alternative energy (e.g., solar), oil or gas pipelines, liquefied natural gas terminals, or hydropower projects. In addition, the bill limits executive power by (1) exempting certain projects related to oil pipelines, natural gas pipelines, or electric transmission facilities from permits required under any executive orders; and (2) rescinding Executive Order 13990, which is about protecting public health and the environment and addressing climate change. Further, the Office of Management and Budget must initiate a rule making that establishes a process to delegate the authority to approve or deny certain oil or gas projects on federal land to states that contain the federal land. The bill also provides statutory authority for rules issued in 2020 and titled (1) Update to the Regulations Implementing the Procedural Provisions of the National Environmental Policy Act ; and (2) The Navigable Waters Protection Rule: Definition of "Waters of the United States ." Finally, the bill terminates a tax credit for certain clean vehicles placed in service after 2024 (currently 2032).
Bill· SS. 799 (118th)referred
United States · United States Congress · 14 March 2023
Chiropractic Medicare Coverage Modernization Act of 2023 This bill expands Medicare coverage of chiropractic services to include all services provided by chiropractors, rather than only subluxation corrections through manual manipulation of the spine.
Bill· SS. 775 (118th)referred
United States · United States Congress · 14 March 2023
Increasing Transparency in Generic Drug Applications Act This bill requires the Food and Drug Administration (FDA) to inform generic drug applicants, upon request or during review, whether the drug is qualitatively and quantitatively the same as the listed brand-name drug (and if not, the reasons why). The FDA must also update or publish guidance on how it makes such determinations.
Bill· SS. 793 (118th)referred
United States · United States Congress · 14 March 2023
Prevent Interruptions in Physical Therapy Act of 2023 This bill allows a physical therapist to receive payment under Medicare for services provided to the physical therapist's patients by another physical therapist through a qualifying temporary arrangement, regardless of the geographic area or population served. Currently, physical therapists may only receive payment with respect to such arrangements for services provided in medically underserved, rural, or health professional shortage areas.
Bill· HRH.R. 1565 (118th)referred
United States · United States Congress · 10 March 2023
Critical Access Hospital Relief Act of 2023 This bill repeals the 96-hour physician-certification requirement for inpatient critical access hospital services under Medicare. Under current law, as a condition for Medicare payment for such services, a physician must certify that a patient may reasonably be expected to be discharged or transferred to a hospital within 96 hours after admission to the critical access hospital.
Bill· HRH.R. 1550 (118th)referred
United States · United States Congress · 10 March 2023
Jobs and Opportunities for SNAP Act This bill expands applicability of the work requirements for Supplemental Nutrition Assistance Program (SNAP) recipients who are able-bodied adults without dependents (ABAWDs). (SNAP recipients who are ABAWDs have work-related requirements in addition to the general SNAP work registration and employment and training requirements.) Specifically, this bill applies the work requirements for ABAWDs to adults who are not over 65 years old, whereas these requirements currently apply to adults who are not over 50 years old. Further, the ABAWD exemption for a parent or household member with responsibility for a dependent child is restricted to a dependent child under the age of seven. Currently, the child must be under the age of 18. The bill repeals COVID-19 public health emergency waivers issued for ABAWD work requirements. The bill also repeals an ABAWD waiver program that allows state exemptions based on an area (1) having an unemployment rate of over 10%, or (2) not having a sufficient number of jobs. Under current law, a state agency may exempt up to 12% of SNAP recipients from the ABAWD work requirements for each fiscal year; unused exemptions may be carried over and used in a subsequent fiscal year. The bill reduces the percentage of exemptions a state agency may provide to up to 3% of SNAP recipients and unused exemptions may not be carried over.
Bill· HRH.R. 1551 (118th)referred
United States · United States Congress · 10 March 2023
Jobs and Opportunities for Medicaid Act This bill establishes work requirements under Medicaid for able-bodied adults. Specifically, the bill requires individuals who are between the ages of 18 and 65 and who are not otherwise unable to work due to a medical condition, family situation, or other listed reason to work or volunteer at least 20 hours per week, based on a monthly average, in order to qualify for Medicaid.
Resolution· HRESH.Res. 224 (118th)referred
United States · United States Congress · 10 March 2023
This resolution recognizes the deadly impact colorectal cancer; acknowledges racial disparities in the impact of colorectal cancer, particularly in the Black community; and encourages actions to address colorectal cancer and those disparities.
Report· HearingS.Hrg.118-117published
United States · United States Senate · 9 March 2023
Bill· HRH.R. 1488 (118th)referred
United States · United States Congress · 9 March 2023
Affordable Insulin Now Act This bill limits cost-sharing for insulin under private health insurance. Specifically, the bill caps cost-sharing under private health insurance for a month's supply of selected insulin products at $35 or 25% of a plan's negotiated price (after any price concessions), whichever is less, beginning in 2024.
Bill· HRH.R. 1526 (118th)referred
United States · United States Congress · 9 March 2023
Reducing Hereditary Cancer Act This bill provides for Medicare coverage of germline mutation testing for individuals with a personal or family history of a hereditary cancer gene mutation or suspected history of hereditary cancer, as well as for associated coverage of risk-reducing surgeries and screenings.
Bill· HRH.R. 1512 (118th)referred
United States · United States Congress · 9 March 2023
Greater Access to Contraceptive Options Act This bill requires the Food and Drug Administration to prioritize review of supplemental applications for over-the counter, self-administered contraceptives (i.e., contraception that is administered without the intervention of a health care professional).
Bill· HRH.R. 1493 (118th)referred
United States · United States Congress · 9 March 2023
HCBS Access Act This bill expands coverage of home- and community-based services (HCBS) under Medicaid. It also establishes programs and requirements to support providers who furnish HCBS. Specifically, the bill requires state Medicaid programs to cover HCBS for individuals who (1) are determined to have a functional impairment that affects daily living and that is expected to last at least 90 days, (2) during the five-year period after the bill is enacted, are already receiving HCBS through Medicaid under a demonstration waiver or other state option, or (3) are under the age of 21 and are otherwise eligible. Covered services include home health care services, private nursing services, homemaking assistance, non-emergency and non-medical transportation, and caregiver support. The bill also requires the Office of Management and Budget to revise the Standard Occupational Classification system so that the occupation of direct support professional (i.e., a professional who provides services for individuals with disabilities) is classified under a separate code as a healthcare support occupation. Additionally, the Administration for Community Living must establish a technical assistance center and award grants to government, nonprofit, educational entities, and relevant employers to support training, recruitment, and retention of direct support professionals. The Centers for Medicare & Medicaid Services must study the effects of the bill's implementation on HCBS beneficiaries and the direct care workforce.
Bill· HRH.R. 1502 (118th)referred
United States · United States Congress · 9 March 2023
Comprehensive Opioid Recovery Centers Reauthorization Act of 2023 This bill reauthorizes through FY2028 and modifies competitive grants for comprehensive opioid recovery centers. These centers provide a full continuum of treatment and recovery services to individuals with substance use disorders. In particular, the bill permits applicants for the grants to demonstrate their capacity to provide the required treatment and recovery services through a letter of intent from a partner agency. A partner agency is a nongovernmental organization or other public or private entity (1) that primarily delivers mental health or substance use disorder treatment services, and (2) that the applicant coordinates with to provide the services required by the grant.
Bill· HRH.R. 1503 (118th)referred
United States · United States Congress · 9 March 2023
Prescription Information Modernization Act of 2023 This bill allows health care providers to receive prescribing information for drugs electronically rather than in paper form from manufacturers. Manufacturers must still give providers the option to continue to receive or request the information in paper form. Additionally, the Food and Drug Administration must hold a public workshop to discuss with stakeholders how to optimize the format, accessibility, and usability of prescribing information.
Resolution· HRESH.Res. 214 (118th)referred
United States · United States Congress · 9 March 2023
This resolution expresses support for Deep Vein Thrombosis and Pulmonary Embolism Awareness Month. Deep vein thrombosis is a condition caused by a blood clot in the deep veins of the body; pulmonary embolisms (i.e., where a blood clot breaks off and lodges in the lung) are a potentially life-threatening complication of this condition.
Bill· HRH.R. 1486 (118th)referred
United States · United States Congress · 9 March 2023
Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2023 This bill exempts traditional large and premium cigars from Food and Drug Administration (FDA) regulation and FDA-assessed user fees.
Resolution· HCONRESH.Con.Res. 23 (118th)referred
United States · United States Congress · 9 March 2023
This concurrent resolution recognizes Abortion Provider Appreciation Day.
Resolution· HRESH.Res. 217 (118th)referred
United States · United States Congress · 9 March 2023
This resolution expresses support for the goals and ideals of Endometriosis Awareness Month. Endometriosis is a painful condition in which the tissue that normally lines the inside of the uterus grows outside the uterus.
Bill· HRH.R. 1523 (118th)referred
United States · United States Congress · 9 March 2023
Property Tax Reduction Act of 2023 This bill reduces federal Medicaid funding beginning in FY2025 for certain states that require political subdivisions to contribute funds towards medical assistance. Specifically, the bill applies to states that received, for FY2023, disproportionate share hospital (DSH) allotments greater than six times the national average. (DSHs are hospitals that receive additional payment under Medicaid for treating a large share of low-income patients.) Excepted from the bill are contributions that: (1) are required from a political subdivision that has a population greater than 5 million and imposes a local income tax upon its residents, or (2) were required for administrative expenses as of January 1, 2023.
Bill· HRH.R. 1485 (118th)referred
United States · United States Congress · 9 March 2023
Insulin for All Act of 2023 This bill caps the manufacturer price of insulin at $20 per 1,000 units.
PreviousPage 29 of 30Next